Every year, more than 2 million women worldwide are diagnosed with breast or cervical
cancer, yet where a woman lives, her socioeconomic status, and agency largely determines …

Historically, the prognosis for individuals diagnosed with lung cancer has been bleak.
However, the past 10 years have seen important advances in treatment and diagnosis which …

Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

This review will describe the global patterns and trends of colorectal cancer survival, using
data from the population-based studies or cancer registration. We performed a systematic …

Introduction Postoperative pulmonary complications (PPC) such as atelectasis and
pneumonia are common following lung resection. PPCs have a significant clinical impact on …

Objective In 2001, the National Institute for Health Research Cancer Research Network
(NCRN) was established, leading to a rapid increase in clinical research activity across the …

Background Survival from colorectal cancer has been shown to be lower in Denmark and
England than in comparable high-income countries. We used data from national colorectal …

Matrix metalloproteinases (MMPs) have traditionally been considered as tumor promoting
enzymes as they degrade extracellular matrix components, thus increasing the invasion of …

Much time, effort and investment goes into the diagnosis of symptomatic cancer, with the
expectation that this approach brings clinical benefits. This investment of resources has …

The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is
transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments …